Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? American Heart Association Journals
AG-80308 for dry eye disease on track for Phase 2 clinical trial Ophthalmology Times
AG-80308 for dry eye disease on track for Phase 2 clinical trial – Ophthalmology Times Read Post »
Peptide Synthesis Market Size to Attain USD 1,438.78 Mn by 2035 Precedence Research
Peptide Synthesis Market Size to Attain USD 1,438.78 Mn by 2035 – Precedence Research Read Post »
Rational design of oral delivery nanosystems for hypoglycemic peptides ScienceDirect.com
Combined computational modeling at different scales to understand peptide drug and excipient co-localization Uppsala universitet
New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs Wiley Interdisciplinary Reviews
Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs MedCity News
Evaluation in pig of an intestinal administration device for oral peptide delivery ScienceDirect.com
Found Technology to Overcome Poor Absorption Drawback of ‘Peptide’ Drugs 아시아경제
Found Technology to Overcome Poor Absorption Drawback of ‘Peptide’ Drugs – 아시아경제 Read Post »
Bile acid transporter-mediated oral drug delivery ScienceDirect.com
Bile acid transporter-mediated oral drug delivery – ScienceDirect.com Read Post »
BEACON Bioeconomy Research Centre and Nuritas to investigate oral bioavailability, a holy grail of the Irish Tech News
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure National Institutes of Health (.gov)
